Košík

ŠŤASTNÁ MARKOVÁ, M.; HAMŠÍKOVÁ, E.; HAINZ, P.; HUBÁČEK, P.; KROUTILOVÁ, M.; KRYŠTOFOVÁ, J.; LUDVÍKOVÁ, V.; MUSIL, J.; PECHERKOVÁ, P.; SALÁKOVÁ, M.; ŠROLLER, V.; VYDRA, J.; NĚMEČKOVÁ, Š.^G Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of BK virus-associated haemorrhagic cystitis after allogeneic HSCT. Vaccines. 2021, vol. 9, no. 11, art. no. 1226. ISSN 2076-393X.